Mhy-Lanie Adduru , MD
Co-CEO & Chief Medical Officer, Predictiv
Bio
Mhy-Lanie Adduru is the co-CEO for Predictiv Middle East and the interim Chief Medical Officer for Predictiv US. She is passionate about innovation at the intersection of human-centered and AI-powered medicine. Inspired by her medical training to push for patient-centered healthcare, Mhy-Lanie and her team are bringing genomics medicine and precision medicine to the forefront of care. Prior to joining Predictiv, she led a clinical investigation on the genomics of multidrug-resistant organisms impacting women's health.
Mhy-Lanie holds an M.D. from the University of Queensland. She also completed her Master's in Biotechnology (Bioinformatics) from Johns Hopkins University and holds a B.A. in Anthropology from the University of California at Berkeley.